<https://rdf.molmedb.upol.cz/reference/ref837> <http://purl.org/ontology/bibo/doi> "10.1021/jm8007618"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/pmid> "18983139"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target69>,
		<https://identifiers.org/molmedb/MM16689>,
		<https://identifiers.org/molmedb/MM00474>,
		<https://identifiers.org/molmedb/MM00553>,
		<https://rdf.molmedb.upol.cz/transporter/target138>;
	<http://purl.org/dc/terms/bibliographicCitation> "Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD.: cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem, Volume 51 (22), 2008"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource> .
<https://rdf.molmedb.upol.cz/transporter/tra56346> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref837> .
<https://rdf.molmedb.upol.cz/transporter/tra57476> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref837> .
<https://rdf.molmedb.upol.cz/transporter/tra32037> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref837> .
